Sirius XM Holdings Inc (SIRI) concluded trading on Wednesday at a closing price of $23.95, with 3.48 million shares of worth about $83.42 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -6.43% during that period and on March 26, 2025 the price saw a loss of about -1.20%. Currently the company’s common shares owned by public are about 338.97M shares, out of which, 309.99M shares are available for trading.
Stock saw a price change of 3.77% in past 5 days and over the past one month there was a price change of -2.28%. Year-to-date (YTD), SIRI shares are showing a performance of 5.04% which decreased to -38.27% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $20.47 but also hit the highest price of $41.60 during that period. The average intraday trading volume for Sirius XM Holdings Inc shares is 5.25 million. The stock is currently trading 2.02% above its 20-day simple moving average (SMA20), while that difference is up 0.62% for SMA50 and it goes to -10.74% lower than SMA200.
Sirius XM Holdings Inc (NASDAQ: SIRI) currently have 338.97M outstanding shares and institutions hold larger chunk of about 75.60% of that.
The stock has a current market capitalization of $8.11B and its 3Y-monthly beta is at 0.97. It has posted earnings per share of -$4.94 in the same period. It has Quick Ratio of 0.42 while making debt-to-equity ratio of 0.94. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SIRI, volatility over the week remained 2.65% while standing at 3.91% over the month.
Stock’s fiscal year EPS is expected to rise by 150.45% while it is estimated to increase by 1.15% in next year.
Coverage by BofA Securities stated Sirius XM Holdings Inc (SIRI) stock as an Underperform in their note to investors on October 24, 2024, suggesting a price target of $23 for the stock. On October 09, 2024, JP Morgan Resumed their recommendations, while on September 24, 2024, Morgan Stanley Resumed their ratings for the stock with a price target of $23. Stock get a Buy rating from Guggenheim on September 18, 2024.
